Table III.

Mean percentage of Th1 (IL2, IFNγ) and Th2-like (IL4, IL10) T (CD3), cytotoxic (CD8) and helper (CD4) cell proportions in PBMCs from breast cancer patients at T2 and T3.

T2
	A Reflexology + SIS	B Massage + SIS	C SIS	A vs. B vs. C f-test p-value	A vs. B f-test p-value	A vs. C f-test p-value	B vs. C f-test p-value
CD3/IL2	23.5±1.5	25.2±1.5	22.5±1.6	0.45	1.00	1.00	0.64
CD3/IFNγ	19.3±1.1	20.3±1.1	17.2±1.2	0.17	1.00	0.61	0.19
CD3/IL4	2.9±1.1	3.9±1.1	4.9±1.2	0.48	1.00	0.69	1.00
CD3/IL10	1.2±0.4	1.5±0.4	0.9±0.4	0.63	1.00	1.00	1.00
CD8/IL2	2.6±0.2	2.8±0.2	2.5±0.2	0.59	1.00	1.00	0.93
CD8/IFNγ	8.1±0.6	9.2±0.6	8.0±0.6	0.26	0.51	1.00	0.45
CD8/IL4	0.8±0.17	1.2±0.2	1.0±0.2	0.21	0.25	0.92	1.00
CD8/IL10	0.4±0.15	0.4±0.2	0.5±0.2	0.82	1.00	1.00	1.00
CD4/IL2	20.9±1.4	22.5±1.4	20.0±1.5	0.46	1.00	1.00	0.66
CD4/IFNγ	10.7±0.8	11.2±0.8	9.6±0.8	0.32	1.00	0.87	0.43
CD4/IL4	1.8±1.1	2.9±1.2	4.1±1.2	0.38	1.00	0.49	1.00
CD4/IL10	0.7±0.4	1.1±0.4	0.6±0.4	0.57	1.00	1.00	1.00
T3
CD3/IL2	26.7±1.7	26.7±1.8	26.0±1.8	0.94	1.00	1.00	1.00
CD3/IFNγ	20.5±1.0	21.2±1.1	19.5±1.1	0.52	1.00	1.00	0.76
CD3/IL4	3.7±0.6	2.5±0.6	4.8±0.6	0.03a	0.44	0.56	0.02a
CD3/IL10	0.9±0.2	0.8±0.2	0.9±0.2	0.72	1.00	1.00	1.00
CD8/IL2	3.0±0.2	2.8±0.3	2.5±0.3	0.48	1.00	0.70	1.00
CD8/IFNγ	9.4±0.6	10.6±0.6	8.3±0.6	0.03a	0.45	0.59	0.02a
CD8/IL4	1.7±0.3	1.0±0.3	1.0±0.3	0.07	0.12	0.17	1.00
CD8/IL10	0.3±0.1	0.2±0.1	0.3±0.1	0.86	1.00	1.00	1.00
CD4/IL2	24.9±1.6	24.1±1.7	23.5±1.7	0.82	1.00	1.00	1.00
CD4/IFNγ	11.6±0.7	11.1±0.7	11.2±0.7	0.89	1.00	1.00	1.00
CD4/IL4	2.7±0.6	1.7±0.6	3.7±0.6	0.02a	0.9	0.20	0.02a
CD4/IL10	0.8±0.2	0.6±0.2	0.7±0.2	0.85	1.00	1.00	1.00

Values are estimated marginal mean ± SEM.

^aDenotes significant values. Also shown are the results from the univariate analysis of variance. All values are adjusted for baseline.